NASDAQ · Biotechnology

Exicure, Inc. (XCUR) Stock

$1.05 +5.00% NASDAQ: XCUR Healthcare

Valuation

MetricValue
Price$1.05
Market Cap$6.69M
P/E Ratio-0.87
P/B Ratio7.44
P/S Ratio0.00
EPS (TTM)$-0.79
52-Week High$9.48
52-Week Low$0.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-237.91%
ROA-72.69%
ROCE-101.07%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$29.0M$0$1.0M$0
Operating Profit$-63.0M$-2.0M$-15.0M$-12.0M$-10.0M
Net Profit$-64.0M$-3.0M$-17.0M$-10.0M$-5.0M
EPS$-21.70$-0.56$-2.11$-1.59$-0.79
Op Margin12950.1%-6.3%—-2446.4%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$65.0M$23.0M$12.0M$15.0M$14.0M
Total Liabilities$54.0M$8.0M$9.0M$8.0M$10.0M
Cash$35.0M$9.0M$1.0M$13.0M$4.0M
Borrowings$15.0M$7.0M$7.0M$6.0M$0

Latest News

Exicure Announces Board and Committee Changes GlobeNewswire · Jun 30, 2026 Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement GlobeNewswire · Jun 10, 2026 Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q GlobeNewswire · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-36.0M$-10.0M$-3.0M$-9.0M
Investing Cash Flow$42.0M$5.0M$-1.0M$0$-2.0M
Financing Cash Flow$0$-1.0M$-2.0M$0$0
Net Cash Flow$9.0M$-34.0M$-8.0M$10.0M$-9.0M
Free Cash Flow$-36.0M$-36.0M$-10.0M$-3.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.65
FCF Yield-87.87%
Quick Ratio0.56
Interest Coverage-7304.00
Return 1Y-76.35%
Return 3Y-76.18%
Return 5Y-99.23%

Ownership

Insiders Held42.59%
Institutions Held2.69%
Institutions Float Held4.69%
Institutional HolderSharesReport Date
Carlyle Group Inc.56,3282026-03-31
Geode Capital Management, LLC36,9132026-03-31
Vanguard Capital Management LLC32,9832026-03-31
Vanguard Fiduciary Trust Co13,1612026-03-31
Northern Trust Corporation10,6862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLGNCollPlant Biotechnologies Ltd. $3.51 -11.59% -0.37 $4.55M 0.00%
CVKDCadrenal Therapeutics, Inc. $0.91 -2.10% -0.19 $3.25M 0.00%
IBIOiBio, Inc. $0.87 -5.33% -3.46 $56.01M 0.00%
KLTOKlotho Neurosciences, Inc. $0.38 -7.10% -1.13 $20.08M 0.00%
MTVAMetaVia Inc. $1.41 +5.22% -0.38 $9.29M 0.00%

About Exicure, Inc.

Exicure, Inc. is led by CEO Jungsoo Kim, employs 7 people, headquartered in US, publicly traded since 2018.

Exicure, Inc. (XCUR) stock trades at $1.05 with a market capitalization of $6.69M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.87, reflecting a net loss over the last twelve months, price-to-book of 7.44, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.96 and $9.48, and currently trades 88.9% below its 52-week high.

On profitability, Exicure, Inc. generates a return on equity (ROE) of -237.91% (negative, reflecting a net loss), return on capital employed of -101.07%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.